K. Brown, P. Yang, D. Salvador, R. Kulikauskas, H. Ruohola-baker et al., WNT/?-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner, Oncogene, vol.36, pp.3119-3136, 2017.

H. Cam, E. Balciunaite, A. Blais, A. Spektor, R. C. Scarpulla et al., A common set of gene regulatory networks links metabolism and growth inhibition, Mol. Cell, vol.16, pp.399-411, 2004.

R. Camarda, J. Williams, and A. Goga, In vivo reprogramming of cancer metabolism by MYC. Front, Cell. Dev. Biol, vol.5, p.35, 2017.

F. Cong, L. Schweizer, and H. Varmus, Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP, Development, vol.131, pp.5103-5115, 2004.

J. Cox, M. Y. Hein, C. A. Luber, I. Paron, N. Nagaraj et al., Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ, Mol. Cell. Proteomics, vol.13, pp.2513-2526, 2014.

J. Cox and M. Mann, MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification, Nat. Biotechnol, vol.26, pp.1367-1372, 2008.

J. Cox, N. Neuhauser, A. Michalski, R. A. Scheltema, J. V. Olsen et al., Andromeda: a peptide search engine integrated into the MaxQuant environment, J. Proteome Res, vol.10, pp.1794-1805, 2011.

M. Duhamel, F. Rodet, N. Delhem, F. Vanden-abeele, F. Kobeissy et al., Molecular consequences of proprotein convertase 1/3 (PC1/3) inhibition in macrophages for application to cancer immunotherapy: a proteomic study, Mol. Cell Proteomics, vol.14, pp.2857-2877, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01850616

F. Fischer, J. D. Langer, and H. D. Osiewacz, Identification of potential mitochondrial CLPXP protease interactors and substrates suggests its central role in energy metabolism, Sci. Rep, vol.5, p.18375, 2015.

F. C. Geyer, M. Lacroix-triki, K. Savage, M. Arnedos, M. B. Lambros et al., ?-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation, Mod. Pathol, vol.24, pp.209-231, 2011.

A. M. Giudetti, F. Damiano, G. V. Gnoni, and L. Siculella, Low level of hydrogen peroxide induces lipid synthesis in BRL-3A cells through a CAPindependent SREBP-1a activation, Int. J. Biochem. Cell. Biol, vol.45, pp.1419-1426, 2013.

F. Guerra, I. Kurelac, A. Cormio, R. Zuntini, L. B. Amato et al., Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma, Hum. Mol. Genet, vol.20, pp.2394-2405, 2011.

R. Hashizume, H. Koizumi, A. Ihara, T. Ohta, and T. Uchikoshi, Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin, Histopathology, vol.29, pp.139-146, 1996.

A. Herbst, V. Jurinovic, S. Krebs, S. E. Thieme, H. Blum et al., Comprehensive analysis of ?-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/?-catenin signaling, BMC Genomics, vol.15, p.74, 2014.

A. H. Huber and W. I. Weis, The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin, Cell, vol.105, pp.391-402, 2001.

G. B. Jang, J. Y. Kim, S. D. Cho, K. S. Park, .. J. Jung et al., Blockade of Wnt/?-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype, Sci. Rep, vol.5, p.12465, 2015.

Z. Keckesova, J. L. Donaher, J. De-cock, E. Freinkman, S. Lingrell et al., LACTB is a tumour suppressor that modulates lipid metabolism and cell state, Nature, vol.543, pp.681-686, 2017.

R. Lamb, M. P. Ablett, K. Spence, G. Landberg, A. H. Sims et al., Wnt pathway activity in breast cancer sub-types and stem-like cells, PLoS ONE, vol.8, p.67811, 2013.

S. Lamouille, J. Xu, and R. Derynck, Molecular mechanisms of epithelial-mesenchymal transition, Nat. Rev. Mol. Cell Biol, vol.15, pp.178-196, 2014.

H. Liang and W. F. Ward, PGC-1alpha: a key regulator of energy metabolism, Adv. Physiol. Educ, vol.30, pp.145-151, 2006.

B. T. Macdonald, K. Tamai, and X. He, Wnt/beta-catenin signaling: components, mechanisms, and diseases, Dev. Cell, vol.17, pp.9-26, 2009.

A. H. Mekkawy, D. L. Morris, and M. H. Pourgholami, HAX1 augments cell proliferation, migration, adhesion, and invasion induced by urokinase-type plasminogen activator receptor, J. Oncol, p.950749, 2012.

H. Mi, A. Muruganujan, J. T. Casagrande, and P. D. Thomas, Large-scale gene function analysis with the PANTHER classification system, Nat. Prot, vol.8, pp.1551-1566, 2013.

F. Morrish and D. Hockenbery, MYC and mitochondrial biogenesis, Cold Spring Harb. Perspect. Med, vol.4, p.14225, 2014.

A. Nath, C. , and C. , Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers, Sci. Rep, vol.6, p.18669, 2016.

T. T. Onder, P. B. Gupta, S. A. Mani, J. Yang, E. S. Lander et al., Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways, Cancer Res, vol.68, pp.3645-3654, 2008.

R. C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy et al., Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc, 2000.

, J. Biol. Chem, vol.275, pp.21797-21800

P. Priore, A. M. Giudetti, F. Natali, G. V. Gnoni, and M. J. Geelen, Metabolism and short-term metabolic effects of conjugated linoleic acids in rat hepatocytes, Biochim. Biophys. Acta, vol.1771, pp.1299-1307, 2007.

P. M. Quirós, T. Langer, and C. López-otín, New roles for mitochondrial proteases in health, ageing and disease, Nat. Rev. Mol. Cell. Biol, vol.16, pp.345-359, 2015.

A. G. Ramsay, M. D. Keppler, M. Jazayeri, G. J. Thomas, M. Parsons et al., HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6, Cancer Res, vol.67, pp.5275-5284, 2007.

F. Röhrig and A. Schulze, The multifaceted roles of fatty acid synthesis in cancer, Nat. Rev. Cancer, vol.16, pp.732-749, 2016.

B. Schade, R. Lesurf, V. Sanguin-gendreau, T. Bui, G. Deblois et al., ?-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression, Cancer Res, vol.73, pp.4474-4487, 2013.

V. Seitz, P. Butzhammer, B. Hirsch, J. Hecht, I. Gütgemann et al., Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma, PLoS ONE, vol.6, p.26837, 2011.

G. Serviddio, F. Bellanti, E. Stanca, P. Lunetti, M. Blonda et al., Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis. Free Radic, Biol. Med, vol.73, pp.117-126, 2014.

J. Song, Z. Wang, and R. M. Ewing, Integrated analysis of the Wnt responsive proteome in human cells reveals diverse and cell-type specific networks, Mol. Biosyst, vol.10, pp.45-53, 2014.

F. Sotgia, D. Whitaker-menezes, U. E. Martinez-outschoorn, A. F. Salem, A. Tsirigos et al., Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells, Cell Cycle, vol.11, pp.4390-4401, 2012.

O. Tetsu and F. Mccormick, Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells, Nature, vol.398, pp.422-426, 1999.

J. Teulière, M. M. Faraldo, M. A. Deugnier, M. Shtutman, A. Ben-ze'ev et al., Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia, Development, vol.132, pp.267-277, 2005.

J. P. Thiery and J. P. Sleeman, Complex networks orchestrate epithelial-mesenchymal transitions, Nat. Rev. Mol. Cell Biol, vol.7, pp.131-142, 2006.

X. Tian, Z. Liu, B. Niu, J. Zhang, T. K. Tan et al., E-cadherin/?catenin complex and the epithelial barrier, J. Biomed. Biotechnol, p.567305, 2011.

M. Trerotola, J. Li, S. Alberti, and L. R. Languino, Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the ?1 integrin-RACK1 axis, J. Cell. Physiol, vol.227, pp.3670-3677, 2012.

B. Tung, B. Schade, R. D. Cardiff, O. H. Aina, V. Sanguin-gendreau et al., ?-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model, Proc. Natl. Acad. Sci. U.S.A, vol.114, pp.707-716, 2017.

D. Vergara, M. M. Ferraro, M. Cascione, L. L. Del-mercato, S. Leporatti et al., Cytoskeletal alterations and biomechanical properties of parkin-mutant human primary fibroblasts, Cell. Biochem. Biophys, vol.71, pp.1395-1404, 2015.

D. Vergara, P. Simeone, S. De-matteis, S. Carloni, P. Lanuti et al., Comparative proteomic profiling of Hodgkin lymphoma cell lines, Mol. Biosyst, vol.12, pp.219-232, 2016.

S. Wang, Z. Sun, X. Zhang, Z. Li, M. Wu et al., Wnt1 positively regulates CD36 expression via TCF4 and PPAR-? in macrophages, Cell. Physiol. Biochem, vol.35, pp.1289-1302, 2015.

J. R. Wi?niewski, A. Zougman, N. Nagaraj, and M. Mann, Universal sample preparation method for proteome analysis, Nat. Methods, vol.6, pp.359-362, 2009.

G. Yang, A. A. Goltsov, C. Ren, S. Kurosaka, K. Edamura et al., Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer, Mol. Cancer Res, vol.10, pp.218-229, 2012.

J. C. Yoon, A. Ng, B. H. Kim, A. Bianco, R. J. Xavier et al., Wnt signaling regulates mitochondrial physiology and insulin sensitivity, Genes Dev, vol.24, pp.1507-1518, 2010.

T. Zhan, N. Rindtorff, and M. Boutros, Wnt signaling in cancer, Oncogene, vol.36, pp.1461-1473, 2017.

S. Zhao, A. Torres, R. A. Henry, S. Trefely, M. Wallace et al., , 2016.

. Atp-citrate, Lyase Controls a Glucose-to-Acetate Metabolic Switch, Cell Rep, vol.17, pp.1037-1052